Variant position: 304 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 332 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human QVYQKEQCPAGHQVMKEAFG PEDGLQRLTWWCPQCQPQLS-E
Mouse QIYQKEQCPSGHQVMKETFG PPDGLQRLTWWCPQCQPQLSS
Bovine QIYQKEQCPAGHQVVRESLG PPGGFQRLTWWCPQCQPRLSA
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
2 – 332 Endonuclease 8-like 2
284 – 320 FPG-type
310 – 310 Proton donor; for delta-elimination activity
291 – 291 C -> S. Loss of glycosylase and AP lyase activity.
295 – 295 H -> A. Loss of glycosylase and AP lyase activity.
310 – 310 R -> Q. Strongly reduces strand AP lyase activity.
315 – 315 C -> S. Loss of glycosylase and AP lyase activity.
318 – 318 C -> S. Loss of glycosylase and AP lyase activity.
NIEHS SNPs program;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS SER-70; GLN-103; TRP-103; LEU-257 AND THR-304;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.